RXi Pharmaceuticals

eyes
Biotech

Early trial shows application of RXi’s skin-scar drug in wet AMD

RXi’s drug designed to reduce scar formation showed positive safety and efficacy results in an early-phase study of patients with a form of wet AMD.
Conor Hale Aug 1, 2018 2:42pm
parachute3

Chutes & Ladders—Embattled Juno taps new R&D head

Apr 20, 2017 5:49pm